Label: STRIDEX XL FACE AND BODY PADS- salicylic acid liquid
- NDC Code(s): 10157-2114-1
- Packager: Blistex Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 14, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Uses
- Warnings
-
Directions
- clean the skin thoroughly before applying this product
- use the pad to cover the entire affected area with a thin layer one to three times daily
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day
- do not leave pad on skin for an extended period of time
- keep away from eyes, lips and other mucous membranes
- Other information
- Inactive ingredients
- PRINCIPAL DISPLAY PANEL - 90 Pad Jar Carton
-
INGREDIENTS AND APPEARANCE
STRIDEX XL FACE AND BODY PADS
salicylic acid liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:10157-2114 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid 2 g in 100 mL Inactive Ingredients Ingredient Name Strength water (UNII: 059QF0KO0R) sodium borate (UNII: 91MBZ8H3QO) .alpha.-chlorohydrin, (+/-)- (UNII: QGS78A3T6P) pummelo (UNII: ET1TN5W71X) ammonium lauryl sulfate (UNII: Q7AO2R1M0B) ammonium xylenesulfonate (UNII: 4FZY6L6XCM) citric acid monohydrate (UNII: 2968PHW8QP) phenoxyethanol (UNII: HIE492ZZ3T) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) silicon dioxide (UNII: ETJ7Z6XBU4) edetate sodium (UNII: MP1J8420LU) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:10157-2114-1 1 in 1 CARTON 09/20/2020 1 90 in 1 JAR 1 2 mL in 1 APPLICATOR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part333D 09/20/2020 Labeler - Blistex Inc (005126354) Establishment Name Address ID/FEI Business Operations Blistex Inc 005126354 MANUFACTURE(10157-2114)